Clinical Trial Update: NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures [Phase 4]

View source ↗

Summary

This entry notes an ongoing Phase 4 clinical trial evaluating the NovaLign Intramedullary Fixation System for humeral fractures; the current status of the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Humeral Fracture

Drugs mentioned

• NovaLign Intramedullary Fixation System (IFS)

Snippet

Sponsor: NovaLign Orthopaedics, Inc | Conditions: Fracture | Phase 4 | Status: UNKNOWN